✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
PF-04457845 is an investigational drug.
There have been 9 clinical trials for PF-04457845. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Marijuana Abuse, Osteoarthritis, Knee, and Osteoarthritis. The leading clinical trial sponsors are Pfizer, Yale University, and National Institute on Drug Abuse (NIDA).
Recent Clinical Trials for PF-04457845
|A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder||Pfizer||Phase 2|
|FAAH Inhibitor Trial for Adults With Tourette Syndrome||Tourette Association of America||Phase 1|
|FAAH Inhibitor Trial for Adults With Tourette Syndrome||Yale University||Phase 1|